DRRX Durect Corp

Durect Corp is a biopharmaceutical company. It develops pharmaceutical products based on two categories which include new chemical entities and Drug Delivery Programs.

$4.52  -0.01 (-0.22%)
As of 03/24/2023 11:33:38 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/13/2001
Outstanding shares:  24,484,867
Average volume:  97,951
Market cap:   $112,140,691
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2640835

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%